Investor Presentation Full Year 2021
15
Investor presentation
Full year 2021
Financial results - Full year of 2021
Novo NordiskⓇ
Change
Change
In DKK million
Sales
Gross profit
Gross margin
Sales and distribution costs
Percentage of sales
Full year 2021
140,800
117,142
83.2%
(37,008)
26.3%
Full year 2020
(reported)
(CER)
126,946
11%
14%
106,014
11%
83.5%
(32,928)
12%
15%
25.9%
Research and development costs
(17,772)
(15,462)
15%
16%
Percentage of sales
12.6%
12.2%
Administration costs
(4,050)
(3,958)
2%
4%
Percentage of sales
2.9%
3.1%
Other operating income and expenses
332
460
(28%)
Operating profit
58,644
54,126
8%
13%
Operating margin
41.7%
42.6%
Financial items (net)
436
(996)
Profit before income tax
Income taxes
59,080
(11,323)
53,130
(10,992)
11%
3%
Effective tax rate
19.2%
20.7%
Net profit
47,757
42,138
13%
Diluted earnings per share (DKK)
20.74
18.01
15%
CER: Constant exchange ratesView entire presentation